198 related articles for article (PubMed ID: 1518837)
41. A 100-kDa protein in the C4-activating component of Ra-reactive factor is a new serine protease having module organization similar to C1r and C1s.
Takayama Y; Takada F; Takahashi A; Kawakami M
J Immunol; 1994 Mar; 152(5):2308-16. PubMed ID: 8133044
[TBL] [Abstract][Full Text] [Related]
42. The human complement system: assembly of the classical pathway C3 convertase.
Kerr MA
Biochem J; 1980 Jul; 189(1):173-81. PubMed ID: 6906228
[TBL] [Abstract][Full Text] [Related]
43. Importance of the prime subsites of the C1s protease of the classical complement pathway for recognition of substrates.
O'Brien G; Quinsey NS; Whisstock JC; Pike RN
Biochemistry; 2003 Dec; 42(50):14939-45. PubMed ID: 14674770
[TBL] [Abstract][Full Text] [Related]
44. [Mechanism of complement activity].
Chenchikova EP
Zh Mikrobiol Epidemiol Immunobiol; 1978 Jul; (7):21-31. PubMed ID: 308752
[No Abstract] [Full Text] [Related]
45. Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.
Fearon DT; Daha MR; Strom TB; Weiler JM; Carpenter CB; Austen KF
Transplant Proc; 1977 Mar; 9(1):729-39. PubMed ID: 325806
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.
Sahu A; Kay BK; Lambris JD
J Immunol; 1996 Jul; 157(2):884-91. PubMed ID: 8752942
[TBL] [Abstract][Full Text] [Related]
47. Complement activation by C-reactive protein on the HEp-2 cell substrate.
Vaith P; Prasauskas V; Potempa LA; Peter HH
Int Arch Allergy Immunol; 1996 Oct; 111(2):107-17. PubMed ID: 8859218
[TBL] [Abstract][Full Text] [Related]
48. Identification of HIV-1 protease cleavage site in human C1-inhibitor.
Gerencer M; Burek V
Virus Res; 2004 Sep; 105(1):97-100. PubMed ID: 15325085
[TBL] [Abstract][Full Text] [Related]
49. Two clusters of acidic amino acids near the NH2 terminus of complement component C4 alpha'-chain are important for C2 binding.
Pan Q; Ebanks RO; Isenman DE
J Immunol; 2000 Sep; 165(5):2518-27. PubMed ID: 10946278
[TBL] [Abstract][Full Text] [Related]
50. Cloning and structure of three rainbow trout C3 molecules: a plausible explanation for their functional diversity.
Zarkadis IK; Sarrias MR; Sfyroera G; Sunyer JO; Lambris JD
Dev Comp Immunol; 2001 Jan; 25(1):11-24. PubMed ID: 10980316
[TBL] [Abstract][Full Text] [Related]
51. A novel human complement-related protein, C1r-like protease (C1r-LP), specifically cleaves pro-C1s.
Ligoudistianou C; Xu Y; Garnier G; Circolo A; Volanakis JE
Biochem J; 2005 Apr; 387(Pt 1):165-73. PubMed ID: 15527420
[TBL] [Abstract][Full Text] [Related]
52. Structure of the catalytic region of human complement protease C1s: study by chemical cross-linking and three-dimensional homology modeling.
Rossi V; Gaboriaud C; Lacroix M; Ulrich J; Fontecilla-Camps JC; Gagnon J; Arlaud GJ
Biochemistry; 1995 Jun; 34(22):7311-21. PubMed ID: 7779774
[TBL] [Abstract][Full Text] [Related]
53. Complement-inhibiting peptides identified by proximity to indels in the C3/4/5 protein family.
Ogata RT; Low PJ
J Immunol; 1997 Apr; 158(8):3852-60. PubMed ID: 9103453
[TBL] [Abstract][Full Text] [Related]
54. A complement-resistant HeLa cell line (T638) is blocked at the step of C3 deposition.
Santi P; Joiner KA; Hammer CH; Frank MM; Tosi R
J Immunol; 1987 May; 138(10):3385-91. PubMed ID: 2952716
[TBL] [Abstract][Full Text] [Related]
55. A covalent dimer of complement C4b serves as a subunit of a novel C5 convertase that involves no C3 derivatives.
Masaki T; Matsumoto M; Yasuda R; Levine RP; Kitamura H; Seya T
J Immunol; 1991 Aug; 147(3):927-32. PubMed ID: 1861081
[TBL] [Abstract][Full Text] [Related]
56. Primary structure of cobra complement component C3.
Fritzinger DC; Petrella EC; Connelly MB; Bredehorst R; Vogel CW
J Immunol; 1992 Dec; 149(11):3554-62. PubMed ID: 1431125
[TBL] [Abstract][Full Text] [Related]
57. The binding of human complement component C4 to antibody-antigen aggregates.
Campbell RD; Dodds AW; Porter RR
Biochem J; 1980 Jul; 189(1):67-80. PubMed ID: 6906229
[TBL] [Abstract][Full Text] [Related]
58. Elucidation of the substrate specificity of the C1s protease of the classical complement pathway.
Kerr FK; O'Brien G; Quinsey NS; Whisstock JC; Boyd S; de la Banda MG; Kaiserman D; Matthews AY; Bird PI; Pike RN
J Biol Chem; 2005 Nov; 280(47):39510-4. PubMed ID: 16169853
[TBL] [Abstract][Full Text] [Related]
59. Effect of sodium chloride concentration on fluid-phase assembly and stability of the C3 convertase of the classical pathway of the complement system.
Maeda S; Nagasawa S
Biochem J; 1990 Nov; 271(3):749-54. PubMed ID: 2244876
[TBL] [Abstract][Full Text] [Related]
60. Solution Structures of Complement C2 and Its C4 Complexes Propose Pathway-specific Mechanisms for Control and Activation of the Complement Proconvertases.
Mortensen S; Jensen JK; Andersen GR
J Biol Chem; 2016 Aug; 291(32):16494-507. PubMed ID: 27252379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
